by Jessica Hamzelou from MIT Technology Review on (#768R7)
Earlier this week, Life Biosciences, a biotech company focused on reversing age-related diseases, announced that it had dosed its first volunteer. A person with glaucoma has had an experimental treatment injected straight into their eyeball. The idea is to try to treat the disease-which can cause vision loss-by regenerating healthy nerves in the eye. But...